CA
NZ
UK
AU
IND
US
Product sales were USD 102.9 million versus USD 217.4 million. NaloxoneRevenuefell USD 31.4 million, or 42%, to USD 43.5 million, mainly because of lower over-the-counter NARCAN sales on an unfavorable price andVolumemix in U.S. public interest channels, partly offset by higher Canadian sales of …
Notable items accounted for USD 41 million of the difference between the two operating figures, so the USD 2.13 per share headline and the USD 1.98 adjusted measure offer two views of underlying performance.
The commercial portfolio was 92.3% occupied, up from 89.4% in June and 90.0% a year earlier, and 95.6% leased versus 94.9% and 92.6%. Office was 91.9% occupied and 95.5% leased, retail was 96.6% occupied and 96.8% leased, and the multifamily portfolio was 97.1% leased.
VariableMarketingDollars, the company's measure of revenue less variableAdvertisingcosts, came to USD 62.6 million versus USD 50.1 million, an increase of about 25% by our calculation. Operating cash flow more than doubled to USD 40.5 million from USD 19.8 million.
Operationally, the company drilled 105 gross wells (100 net) and completed 135 gross wells (133 net) in the quarter, all in the Midland Basin. For the nine months it drilled 320 gross wells and completed 450, with average completed lateral length of 13,584 feet …
The gap between GAAP and non-GAAP results was wide. Non-GAAP net income was USD 157.4 million versus USD 105.3 million, and non-GAAP net income per diluted share was USD 4.34 versus USD 2.92. By our calculation, non-GAAPEarnings Per Sharegrew about 49% while GAAP earnings …
Per share figures reflect a weighted average of about 13.9 million common shares, compared with 12.3 million a year earlier, so income per share fell faster than income in dollars.
The company reported a loss of USD 15.1 million from its investment in a related party investment fund, versus a loss of USD 14.4 million, while net investment income was USD 10.5 million versus a loss of USD 3.0 million. Foreign exchange losses were …
Reported gross margin reached 39.6% in the quarter and 38.0% over nine months, so the quarter ran about 160 basis points above the year-to-date level by our calculation. The company said this improvement came despite year-to-date headwinds from donor center network restructuring costs, the …
Gross profit was USD 1,044.1 million versus USD 989.5 million, equal to a gross margin of 77.3% by our calculation versus 77.7%. Selling expenses rose to USD 473.5 million from USD 450.7 million, and general and administrative expenses rose to USD 432.1 million from …
Please wait processing your request...